MoneyWorks4Me

USFDA completes inspection at central laboratory of Choksi Laboratories in Indore

22 Aug 2026 Evaluate

United States Food & Drug Administration (USFDA) has completed inspection at Choksi Laboratories’ central laboratory located at Indore. The inspection was carried on between August 17, 2026 to August 20, 2026.

On conclusion of the inspection, the company received 4 observations. The company is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe. The Company reaffirms its commitment to fully comply with USFDA regulations and to maintain the highest standards of quality and regulatory compliance at all times. 

Choksi Laboratories (CLL) is widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.


Choksi Laboratories Share Price

147.85 -2.65 (-1.76%)
28-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Indegene 578.65
Syngene Internatl. 403.40
JITF Infralogistics 319.00
CMS Info Systems 242.55
Sagility 46.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: